Company
Catalent, Inc. (0001596783)
Standardized SEC financial data for Catalent, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001596783 · Pharmaceutical Preparations.
Gross margin
21.8%
Operating margin
-17.1%
Net margin
-23.8%
Revenue growth (YoY)
2.8%
Return on equity
-28.9%
ROIC
-7.2%
Free cash flow
-$59.0M
Debt / equity
1.35×
Ratios for fiscal year 2024, standardized from SEC filings.
Income statement
| USD | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Revenue | $2.52B | — | $4.00B | $4.80B | $4.26B | $4.38B |
| Cost of revenue |
Balance sheet
| USD | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $345.0M | $953.0M | $896.0M | $449.0M | $280.0M | $289.0M |
| Inventory |
Cash flow
| USD | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | $248.0M | $440.0M | $433.0M | $439.0M | $254.0M | $268.0M |
| Capital expenditures |
Get 0001596783 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001596783/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001596783/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"